<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(19)</volume><submitter>Takahashi T</submitter><funding>Channel 7 Telethon Trust</funding><funding>Cincinnati Children&amp;apos;s Hospital Medical Center</funding><funding>Stan Perron Charitable Foundation</funding><funding>Women and Infants Research Foundation</funding><pubmed_abstract>Treatment with antenatal steroids (ANS) is standard practice for reducing the risk of respiratory distress in the preterm infant. Despite clear overall benefits when appropriately administered, many fetuses fail to derive benefit from ANS therapies. In standardized experiments using a pregnant sheep model, we have demonstrated that around 40% of ANS-exposed lambs did not have functional lung maturation significantly different from that of saline-treated controls. Surfactant protein A is known to play an important role in lung function. In this genotyping study, we investigated the potential correlation between polymorphisms in SFTPA1, messenger RNA and protein levels, and ventilation outcomes in animals treated with ANS. 45 preterm lambs were delivered 48 h after initial ANS therapy and 44</pubmed_abstract><journal>Physiological reports</journal><pagination>e15477</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9535346</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Single nucleotide polymorphisms in surfactant protein A1 are not associated with a lack of responsiveness to antenatal steroid therapy in a pregnant sheep model.</pubmed_title><pmcid>PMC9535346</pmcid><pubmed_authors>Fee EL</pubmed_authors><pubmed_authors>Takahashi T</pubmed_authors><pubmed_authors>Usuda H</pubmed_authors><pubmed_authors>Jobe AH</pubmed_authors><pubmed_authors>Furfaro L</pubmed_authors><pubmed_authors>Newnham JP</pubmed_authors><pubmed_authors>Kemp MW</pubmed_authors><pubmed_authors>Takahashi Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single nucleotide polymorphisms in surfactant protein A1 are not associated with a lack of responsiveness to antenatal steroid therapy in a pregnant sheep model.</name><description>Treatment with antenatal steroids (ANS) is standard practice for reducing the risk of respiratory distress in the preterm infant. Despite clear overall benefits when appropriately administered, many fetuses fail to derive benefit from ANS therapies. In standardized experiments using a pregnant sheep model, we have demonstrated that around 40% of ANS-exposed lambs did not have functional lung maturation significantly different from that of saline-treated controls. Surfactant protein A is known to play an important role in lung function. In this genotyping study, we investigated the potential correlation between polymorphisms in SFTPA1, messenger RNA and protein levels, and ventilation outcomes in animals treated with ANS. 45 preterm lambs were delivered 48 h after initial ANS therapy and 44</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T22:32:10.005Z</modification><creation>2025-02-19T03:23:02.057Z</creation></dates><accession>S-EPMC9535346</accession><cross_references><pubmed>36200269</pubmed><doi>10.14814/phy2.15477</doi></cross_references></HashMap>